Startseite UB

Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 52.

Article

Meiers, S. and Kemény, M. and Weyand, U. and Gastpar, R. and Angerer, E. von and Marko, D. (2001) The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. Journal of Agricultural and Food Chemistry 49 (2), pp. 958-962.

Golob, T. and Biberger, C. and Walter, G. and Angerer, E. von (2000) Antiestrogenic activities of 3,8-dihydroxy-6,11-dihydrobenzo[a]carbazoles with sulfur-containing side chains. Archiv der Pharmazie 333 (9), pp. 305-311.

Biberger, C. and Angerer, E. von (1998) 1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assays. The Journal of Steroid Biochemistry and Molecular Biology 64 (5-6), pp. 277-285.

Leichtl, S. and Angerer, E. von (1998) 2-Phenylbenzo[b]thiophene-based antiestrogens with mammary tumor inhibiting activity. Archiv der Pharmazie 331 (9), pp. 283-289.

Gastpar, R. and Goldbrunner, M. and Marko, D. and Angerer, E. von (1998) Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization. Journal of Medicinal Chemistry 41 (25), pp. 4965-4972.

Goldbrunner, M. and Loidl, G. and Polossek, T. and Mannschreck, A. and Angerer, E. von (1997) Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives. Journal of Medicinal Chemistry 40 (22), pp. 3524-3533.

Biberger, C. and Angerer, E. von (1996) 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity. The Journal of Steroid Biochemistry and Molecular Biology 58 (1), pp. 31-43.

Hafner, F. and Holler, E. and Angerer, E. von (1996) Effect of growth factors on estrogen receptor mediated gene expression. The Journal of Steroid Biochemistry and Molecular Biology 58 (4), pp. 385-393.

Angerer, E. von and Biberger, C. and Leichtl, S. (1995) Studies on heterocycle-based pure estrogen antagonists. Annals of the New York Academy of Sciences 761, pp. 176-191.

Angerer, E. von and Biberger, C. and Holler, E. and Koop, R. and Leichtl, S. (1994) 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism. The Journal of Steroid Biochemistry and Molecular Biology 49 (1), pp. 51-62.

Meyer, T. and Koop, R. and Angerer, E. von and Schönenberger, H. and Holler, E. (1994) A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. Journal of Cancer Research and Clinical Oncology 120 (6), pp. 359-364.

Maucher, A. and Angerer, E. von (1994) Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas. Journal of cancer research and clinical oncology 120 (8), pp. 502-504.

Angerer, E. von and Kager, M. and Maucher, A. (1994) Antitumour activity of coumarin in prostate and mammary cancer models. Journal of Cancer Research and Clinical Oncology 120 Suppl, S14-S16.

Angerer, S. von and Seidl, E. and Mannschreck, A. and Angerer, E. von and Wiegrebe, Wolfgang (1994) Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells. Anti-cancer drug design 9 (1), pp. 25-40.

Horn, D. W. and Vollmer, G. and Angerer, E. von and Schneider, M. R. (1994) Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma. International journal of cancer. Journal international du cancer 58 (3), pp. 426-429.

Maucher, A. and Angerer, E. von and Hampl, R. and Stárka, L. (1994) The activity of epitestosterone in hormone dependent prostate tumour models. Endocrine regulations 28 (1), pp. 23-29.

Maucher, A. and Angerer, E. von (1993) Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours. Journal of cancer research and clinical oncology 119 (11), pp. 669-674.

Maucher, A. and Kager, M. and Angerer, E. von (1993) Evaluation of the antitumour activity of coumarin in prostate cancer models. Journal of cancer research and clinical oncology 119 (3), pp. 150-154.

Polossek, T. and Ambros, R. and Angerer, S. von and Brandl, G. and Mannschreck, A. and Angerer, E. von (1992) 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity. Journal of Medicinal Chemistry 35 (19), pp. 3537-3547.

Kager, M. and Spruss, T. and Schneider, M. R. and Angerer, E. von (1992) Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation. Journal of cancer research and clinical oncology 118 (5), pp. 334-338.

DiZio, J. P. and Carlson, K. E. and Bannochie, C. J. and Welch, M. J. and Angerer, E. von and Katzenellenbogen, J. A. (1992) Estrogen platinum-diamine complexes: preparation of a non-steroidal estrogen platinum-diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo. The Journal of steroid biochemistry and molecular biology 42 (3-4), pp. 363-373.

Angerer, S. von and Angerer, E. von and Ambros, R. and Wiegrebe, Wolfgang (1992) Ring-cleavage of Phthalidisoquinoline Alkaloids by Ethyl Chloroformate. Archiv der Pharmazie 325, pp. 425-431.

Angerer, E. von and Birnböck, H. and Kager, M. and Maucher, A. (1992) The effect of a combination of zindoxifene and cisplatin on Dunning R3327-G prostatic carcinomas of the rat. Journal of cancer research and clinical oncology 118 (5), pp. 339-343.

Erber, S. and Ringshandl, R. and Angerer, E. von (1991) 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells. Anti-cancer drug design 6 (5), pp. 417-426.

Knebel, N. G. and Angerer, E. von (1991) 2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumors. Journal of Medicinal Chemistry 34 (7), pp. 2145-2152.

Schiller, C. D. and Angerer, E. von and Schneider, M. R. (1991) 6,7-Dihydro-4H-indolones: synthesis and biological properties. Archiv der Pharmazie 324 (10), pp. 767-771.

Schneider, M. R. and Schiller, C. D. and Humm, A. and Angerer, E. von (1991) Effect of zindoxifene on experimental prostatic tumours of the rat. Journal of cancer research and clinical oncology 117 (1), pp. 33-36.

Nishino, Y. and Schneider, M. R. and Michna, H. and Angerer, E. von (1991) Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice. The Journal of endocrinology 130 (3), pp. 409-414.

Angerer, E. von and Knebel, N. and Kager, M. and Ganss, B. (1990) 1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists. Journal of medicinal chemistry 33 (9), pp. 2635-2640.

Stein, R. C. and Dowsett, M. and Cunningham, D. C. and Davenport, J. and Ford, H. T. and Gazet, J. C. and Angerer, E. von and Coombes, R. C. (1990) Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study. British journal of cancer 61 (3), pp. 451-453.

Bednarski, P. J. and Gust, R. and Spruss, T. and Knebel, N. and Otto, A. and Farbel, M. and Koop, R. and Holler, E. and Angerer, E. von and Schönenberger, H. (1990) Platinum compounds with estrogen receptor affinity. Cancer treatment reviews 17 (2-3), pp. 221-231.

Birnböck, H. and Angerer, E. von (1990) Sulfate derivatives of 2-phenylindoles as novel steroid sulfatase inhibitors. An in vitro study on structure-activity-relationship. Biochemical pharmacology 39 (11), pp. 1709-1713.

Erber, S. and Birnböck, H. and Angerer, E. von (1990) Synthesis and biological properties of a 1-(6-aziridinylhexyl)-2-phenylindole, a potential fluorescence label for estrogen receptors. Archiv der Pharmazie 323 (8), pp. 459-463.

Knebel, N. and Schiller, C. D. and Schneider, M. R. and Schönenberger, H. and Angerer, E. von (1989) Carrier mediated action of platinum complexes on estrogen receptor positive tumors. European journal of cancer & clinical oncology 25 (2), pp. 293-299.

Angerer, E. von and Birnböck, H. and Knebel, N. (1989) Platinum complexes with a selective action on estrogen receptor-positive mammary tumors. Anti-cancer drug design 4 (1), pp. 21-35.

Knebel, N. and Angerer, E. von (1988) Platinum complexes with binding affinity for the estrogen receptor. Journal of medicinal chemistry 31 (9), pp. 1675-1679.

Angerer, E. von and Strohmeier, J. (1987) 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity. Journal of medicinal chemistry 30 (1), pp. 131-136.

Schneider, M. R. and Angerer, E. von and Höhn, W. and Sinowatz, F. (1987) Antitumor activity of antiestrogenic phenylindoles on experimental prostate tumors. European journal of cancer & clinical oncology 23 (7), pp. 1005-1015.

Birnböck, H. and Ringshandl, R. and Angerer, E. von (1987) Chromatographic analysis of the new antiestrogen zindoxifene and its metabolites in biological material. Journal of chromatography 414 (1), pp. 235-241.

Strohmeier, J. and Angerer, E. von (1987) Synthesis and estrogen receptor affinity of 2,3-diarylindoles. Archiv der Pharmazie 320 (5), pp. 407-417.

Schneider, M. R. and Angerer, E. von and Prekajac, J. and Brade, W. P. (1986) Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate. Journal of cancer research and clinical oncology 111 (2), pp. 110-114.

Strohmeier, J. and Angerer, E. von (1985) Hydroxy-3-(hydroxyphenyl)indoles. Relationship between structure and estrogen receptor affinity. Archiv der Pharmazie 318 (5), pp. 421-431.

Angerer, E. von and Prekajac, J. and Schneider, M. R. and Berger, M. R. (1985) The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors. Journal of cancer research and clinical oncology 110 (3), pp. 216-220.

Angerer, E. von and Prekajac, J. and Berger, M. (1985) The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors. European journal of cancer & clinical oncology 21 (4), pp. 531-537.

Angerer, E. von and Prekajac, J. and Strohmeier, J. (1984) 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. Journal of medicinal chemistry 27 (11), pp. 1439-47.

Wappes, B. and Jennerwein, M. and Angerer, E. von and Schönenberger, H. and Engel, J. and Berger, M. and Wrobel, K. H. (1984) Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. Journal of medicinal chemistry 27 (10), pp. 1280-1286.

Wappes, B. and Jennerwein, M. and Angerer, E. von and Engel, J. and Schönenberger, H. and Brunner, H. and Schmidt, M. and Berger, M. and Schmähl, D. and Seeber, S. (1984) The tumor-inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II) complexes. Journal of cancer research and clinical oncology 107 (1), pp. 15-20.

Schneider, M. R. and Angerer, E. von and Schönenberger, H. and Michel, R. T. and Fortmeyer, H. P. (1982) 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. Journal of medicinal chemistry 25 (9), pp. 1070-7.

Kranzfelder, G. and Hartmann, R. W. and Angerer, E. von and Schönenberger, H. and Bogden, A. E. (1982) 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Journal of cancer research and clinical oncology 103 (2), pp. 165-180.

Schneider, M. R. and Kranzfelder, G. and Angerer, E. von and Schönenberger, H. and Metzler, M. and Michel, R. T. and Fortmeyer, H. P. and Ruckdeschel, G. (1981) The tumor-inhibiting effect of diethylstilbestrol-3,4-oxide. Journal of cancer research and clinical oncology 100 (3), pp. 247-254.

Angerer, E. von and Kranzfelder, G. and Taneja, A. K. and Schönenberger, H. (1980) N,N'-Dialkylbis(dichlorophenyl)ethylenediamines and -imidazolidines: relationship between structure and estradiol receptor affinity. Journal of medicinal chemistry 23 (12), pp. 1347-1350.

Angerer, E. von and Wiegrebe, Wolfgang (1979) Stereoselektive Synthese des R-(+)-3-Phenyl-isochromans. Archiv der Pharmazie 312 (5), pp. 385-389.

This list was generated on Thu Apr 24 15:09:27 2014 CEST.
  1. University

University Library

Publication Server

Contact person
Gernot Deinzer

Telefon 0941 943-2759
Contact